Acquired Resistance of EGFR-Mutant Lung Cancer to a T790M-Specific EGFR Inhibitor: Emergence of a Third Mutation (C797S) in the EGFR Tyrosine Kinase Domain

被引：201
|
作者：
Yu, Helena A. [1 ,2 ]
Tian, Shaozhou K. [3 ]
Drilon, Alexander E. [1 ,2 ]
Borsu, Laetitia [3 ]
Riely, Gregory J. [1 ,2 ]
Arcila, Maria E. [3 ]
Ladanyi, Marc [3 ,4 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, New York, NY 10021 USA
[2] Weill Cornell Med Coll, Dept Med, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10065 USA
[4] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA
来源：
JAMA ONCOLOGY | 2015年 / 1卷 / 07期
关键词：
MECHANISMS; REVEALS;
D O I：
10.1001/jamaoncol.2015.1066
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：981 / 983
页数：3
相关论文
共 50 条
  • [1] Acquired C797S Mutation upon Treatment with a T790M-Specific Third-Generation EGFR Inhibitor (HM61713) in Non-Small Cell Lung Cancer
    Song, Haa-Na
    Jung, Ki Sun
    Yoo, Kwai Han
    Cho, Jinhyun
    Lee, Ji Yun
    Lim, Sung Hee
    Kim, Hae Su
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Choi, Yoon-La
    Park, Woongyang
    Ahn, Myung-Ju
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : E45 - E47
  • [2] Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Cancer: Distinct Natural History of Patients with Tumors Harboring the T790M Mutation
    Oxnard, Geoffrey R.
    Arcila, Maria E.
    Sima, Camelia S.
    Riely, Gregory J.
    Chmielecki, Juliann
    Kris, Mark G.
    Pao, William
    Ladanyi, Marc
    Miller, Vincent A.
    CLINICAL CANCER RESEARCH, 2011, 17 (06) : 1616 - 1622
  • [3] EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation
    Park, Sehhoon
    Ku, Bo Mi
    Jung, Hyun Ae
    Sun, Jong-Mu
    Ahn, Jin Seok
    Lee, Se-Hoon
    Park, Keunchil
    Ahn, Myung-Ju
    CANCER RESEARCH AND TREATMENT, 2020, 52 (04): : 1288 - 1290
  • [4] Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors
    Jia, Yong
    Yun, Cai-Hong
    Park, Eunyoung
    Rcan, Dalia E.
    Manuia, Mari
    Juarez, Jose
    Xu, Chunxiao
    Rhee, Kevin
    Chen, Ting
    Zhang, Haikuo
    Palakurthi, Sangeetha
    Jang, Jaebong
    Lelais, Gerald
    DiDonato, Michael
    Bursulaya, Badry
    Michellys, Pierre-Yves
    Epple, Robert
    Marsilje, Thomas H.
    McNeill, Matthew
    Lu, Wenshuo
    Harris, Jennifer
    Bender, Steven
    Wong, Kwok-Kin
    Janne, Pasi A.
    Eck, Michael J.
    NATURE, 2016, 534 (7605) : 129 - +
  • [5] Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors
    Yong Jia
    Cai-Hong Yun
    Eunyoung Park
    Dalia Ercan
    Mari Manuia
    Jose Juarez
    Chunxiao Xu
    Kevin Rhee
    Ting Chen
    Haikuo Zhang
    Sangeetha Palakurthi
    Jaebong Jang
    Gerald Lelais
    Michael DiDonato
    Badry Bursulaya
    Pierre-Yves Michellys
    Robert Epple
    Thomas H. Marsilje
    Matthew McNeill
    Wenshuo Lu
    Jennifer Harris
    Steven Bender
    Kwok-Kin Wong
    Pasi A. Jänne
    Michael J. Eck
    Nature, 2016, 534 : 129 - 132
  • [6] Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M
    Kenneth S Thress
    Cloud P Paweletz
    Enriqueta Felip
    Byoung Chul Cho
    Daniel Stetson
    Brian Dougherty
    Zhongwu Lai
    Aleksandra Markovets
    Ana Vivancos
    Yanan Kuang
    Dalia Ercan
    Sarah E Matthews
    Mireille Cantarini
    J Carl Barrett
    Pasi A Jänne
    Geoffrey R Oxnard
    Nature Medicine, 2015, 21 : 560 - 562
  • [7] EGFR T790M and C797S Mutations as Mechanisms of Acquired Resistance to Dacomitinib
    Kobayashi, Yoshihisa
    Fujino, Toshio
    Nishino, Masaya
    Koga, Takamasa
    Chiba, Masato
    Sesumi, Yuichi
    Ohara, Shuta
    Shimoji, Masaki
    Tomizawa, Kenji
    Takemoto, Toshiki
    Mitsudomi, Tetsuya
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (05) : 727 - 731
  • [8] Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M
    Thress, Kenneth S.
    Paweletz, Cloud P.
    Felip, Enriqueta
    Cho, Byoung Chul
    Stetsonl, Daniel
    Dougherty, Brian
    Lai, Zhongwu
    Markovets, Aleksandra
    Vivancos, Ana
    Kuang, Yanan
    Ercan, Dalia
    Matthews, Sarah E.
    Cantarini, Mireille
    Barrett, J. Carl
    Jaenne, Pasi A.
    Oxnard, Geoffrey R.
    NATURE MEDICINE, 2015, 21 (06) : 560 - 562
  • [9] Concomitant ALK translocation and EGFR C797S mutation as resistance mechanisms to osimertinib in an EGFR-mutant NSCLC patient
    Pons-Tostivint, Elvire
    Hulo, Pauline
    Sagan, Christine
    Papazyan, Thomas
    Herbreteau, Guillaume
    Denis, Marc
    RESPIRATORY MEDICINE AND RESEARCH, 2024, 86
  • [10] Acquired EGFR Resistance Mutation C797S in Pancreatic Adenocarcinoma Following Partial Response to Third-Generation EGFR Inhibitor Therapy
    Papa, Brigitte
    Dorwal, Pranav
    Htain, Pamela
    Robin, Julie
    Tan, C. P.
    Singhal, Nimit
    JCO PRECISION ONCOLOGY, 2024, 8
12345